How to choose a microarray service provider

Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has recently published a whitepaper entitled “10 essential questions to ask your microarray service provider”.

The document, which is available to download at OGT’s website, suggests the 10 most important questions a researcher should ask when identifying which microarray service best meets their experimental requirements.

Each service provider is different, offering varying levels of experience and expertise, with some catering for many different applications and others dedicated only to specific areas. This often includes the ability to offer consultancy on various aspects of a study, such as suggesting ways to optimise array and experiment design, sample screening processes and data analysis. In addition, providers use a variety of array platforms and quality control methods, each affecting their suitability for different project requirements. These factors are highly important when deciding on the best service provider to utilise.

The whitepaper provided by OGT will help researchers make better informed decisions when it comes to choosing a microarray service provider, and can be downloaded for free at

To find out more about the full range of products and services offered by OGT, visit


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Oxford Gene Technology. (2011, May 05). How to choose a microarray service provider. News-Medical. Retrieved on May 20, 2022 from

  • MLA

    Oxford Gene Technology. "How to choose a microarray service provider". News-Medical. 20 May 2022. <>.

  • Chicago

    Oxford Gene Technology. "How to choose a microarray service provider". News-Medical. (accessed May 20, 2022).

  • Harvard

    Oxford Gene Technology. 2011. How to choose a microarray service provider. News-Medical, viewed 20 May 2022,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
OGT develops targeted NGS panel for constitutional cytogenetics research